Novo Nordisk 6 may 2026 Novo Nordisk Could Win the Oral GLP-1 Race Against Lilly. Why It Just Raised Guidance. - Barron's
Clinical OMICs 6 may 2026 Epigenetic Markers Link Early-Onset Colon and Rectal Cancer to Specific Pesticide
Clinical OMICs 6 may 2026 Blood Test Reads Cell Spatial Environment to Predict Immunotherapy Response
Eli Lilly 6 may 2026 Meet the minds behind CrossBridge Bio, Eli Lilly's $300M Houston buy - The Business Journals
Vertex 6 may 2026 Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A Strategy (VRTX) - Seeking Alpha
Clinical OMICs 6 may 2026 Advanced Cardiovascular-Kidney-Metabolic Syndrome Linked to Increased Cancer Risk
Edwards Lifesciences 6 may 2026 Resilia tissue developed by Edwards Lifesciences associated with long-term durability - Cardiovascular Business